199 related articles for article (PubMed ID: 14990727)
1. Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.
Shinya K; Fujii Y; Ito H; Ito T; Kawaoka Y
J Virol; 2004 Mar; 78(6):3083-8. PubMed ID: 14990727
[TBL] [Abstract][Full Text] [Related]
2. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.
Watanabe T; Watanabe S; Noda T; Fujii Y; Kawaoka Y
J Virol; 2003 Oct; 77(19):10575-83. PubMed ID: 12970442
[TBL] [Abstract][Full Text] [Related]
4. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
[TBL] [Abstract][Full Text] [Related]
5. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.
Mishin VP; Nedyalkova MS; Hayden FG; Gubareva LV
Vaccine; 2005 Apr; 23(22):2922-7. PubMed ID: 15780741
[TBL] [Abstract][Full Text] [Related]
6. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
7. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice.
Solorzano A; Zheng H; Fodor E; Brownlee GG; Palese P; García-Sastre A
J Gen Virol; 2000 Mar; 81(Pt 3):737-42. PubMed ID: 10675411
[TBL] [Abstract][Full Text] [Related]
8. Live bivalent vaccine for parainfluenza and influenza virus infections.
Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
[TBL] [Abstract][Full Text] [Related]
9. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
10. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
Musthaq SK; Kumar SR; Szyporta M; Kwang J
Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
[TBL] [Abstract][Full Text] [Related]
11. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
12. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
13. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
[TBL] [Abstract][Full Text] [Related]
14. [Study on immunogenicity of a recombinant adenovirus vaccine containing neuraminidase gene of H5N1 influenza virus (A/Anhui/1/2005) in mice].
Ma J; Zhang XG; Li KB; Zhang XM; Wang M; Bai T; Yang L; Xu H; Shu YL; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):449-51. PubMed ID: 20718353
[TBL] [Abstract][Full Text] [Related]
15. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase.
Castrucci MR; Bilsel P; Kawaoka Y
J Virol; 1992 Aug; 66(8):4647-53. PubMed ID: 1378505
[TBL] [Abstract][Full Text] [Related]
17. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
18. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
[TBL] [Abstract][Full Text] [Related]
19. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
